Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
News
Will 100% coverage spur more use of breast cancer chemopreventives?
Publish date:
January 22, 2014
On Twitter
@aliciaault
Pages
« first
1
2
Recommended Reading
Meeting attendees identify top studies presented at SABCS
MDedge Hematology and Oncology
Add-on agents boost neoadjuvant chemo response in triple-negative disease
MDedge Hematology and Oncology
Breast MRI screening finds undetected cancers in 11 per 1,000 average-risk women
MDedge Hematology and Oncology
Findings set stage for immunomodulatory approaches in breast cancer
MDedge Hematology and Oncology
Exercise protects black women against ER-negative breast cancer
MDedge Hematology and Oncology
Primary care screening advised to select women for BRCA counseling
MDedge Hematology and Oncology
Novel treatment promising for chronic neuropathic postmastectomy pain
MDedge Hematology and Oncology
No overall benefit seen with bisphosphonate treatment in chemoresistant breast cancer
MDedge Hematology and Oncology
Survival no better after primary tumor removal in metastatic breast cancer
MDedge Hematology and Oncology
Extracorporeal shock wave therapy promising for lymphedema
MDedge Hematology and Oncology
Breast Cancer
Practice Management
Business of Medicine
All Specialties
